Gedea Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.16M

  • Investors
  • 16

Gedea Biotech General Information

Description

Developer of antibiotic-free therapeutics designed to treat vaginal infections and support vaginal health. The company offers vaginal tablets and therapeutic candidates focused on bacterial vaginosis, vulvovaginal candidiasis, and pre-term birth prevention, enabling women and healthcare providers to manage vaginal infections without the use of antibiotics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Medicon Village
  • Scheeletorget 1
  • 223 81 Lund
  • Sweden
+46 073-352
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Medicon Village
  • Scheeletorget 1
  • 223 81 Lund
  • Sweden
+46 073-352

Gedea Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gedea Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 25-Aug-2025 $1.16M Completed Clinical Trials - Phase 2
13. Grant 08-Nov-2023 Completed Clinical Trials - Phase 2
12. Later Stage VC 05-Jun-2023 Completed Clinical Trials - Phase 2
11. Grant 04-Apr-2023 Completed Clinical Trials - Phase 2
10. Later Stage VC 31-Dec-2020 Completed Clinical Trials - Phase 2
9. Grant 11-Dec-2019 Completed Startup
8. Early Stage VC 31-Dec-2018 Completed Startup
7. Grant 05-Dec-2018 Completed Startup
6. Accelerator/Incubator 01-Jan-2018 $1.34M Completed Startup
5. Early Stage VC 22-Dec-2017 $1.31M $1.34M Completed Startup
To view Gedea Biotech’s complete valuation and funding history, request access »

Gedea Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Preference 27,500 $47.83 $47.83 1x $47.83 24.1%
To view Gedea Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gedea Biotech Patents

Gedea Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4731203-A1 Compositions for promoting growth of lactobacillus crispatus Pending 22-Jun-2023
WO-2024261110-A1 Compositions for promoting growth of lactobacillus crispatus Inactive 22-Jun-2023
EP-4324465-A1 Compounds for use in the treatment of a microbial infection in the urogenital system Inactive 15-Aug-2022
AU-2020252268-A1 Vaginal tablet formulation Active 05-Apr-2019
AU-2020252268-B2 Vaginal tablet formulation Active 05-Apr-2019 A61K31/366
To view Gedea Biotech’s complete patent history, request access »

Gedea Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gedea Biotech Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Additio Capital Venture Capital Minority
Additio Investment Group Venture Capital Minority
Horizon 2020 Government
Medtech4Health Not-For-Profit Venture Capital
You’re viewing 5 of 16 investors. Get the full list »

Gedea Biotech FAQs

  • When was Gedea Biotech founded?

    Gedea Biotech was founded in 2015.

  • Where is Gedea Biotech headquartered?

    Gedea Biotech is headquartered in Lund, Sweden.

  • What is the size of Gedea Biotech?

    Gedea Biotech has 10 total employees.

  • What industry is Gedea Biotech in?

    Gedea Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Gedea Biotech a private or public company?

    Gedea Biotech is a Private company.

  • What is Gedea Biotech’s current revenue?

    The current revenue for Gedea Biotech is .

  • How much funding has Gedea Biotech raised over time?

    Gedea Biotech has raised $6.15M.

  • Who are Gedea Biotech’s investors?

    European Innovation Council, Additio Capital, Additio Investment Group, Horizon 2020, and Medtech4Health are 5 of 16 investors who have invested in Gedea Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process